sarepta therapeutics nasdaq - Search News

Order byBest matchMost fresh

News

Sarepta, Elevidys and European Medicines Agency

InvestorsHub on MSN · 1h

Sarepta shares drop after EU regulators reject Elevidys gene therapy

Shares of Sarepta Therapeutics Inc. (NASDAQ:SRPT) plunged 13% on Friday after a major regulatory blow in Europe. The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) issued a negative opinion on Elevidys,

Continue reading

· 19h · on MSN

Sarepta drops as report suggests FDA needs new trials for Elevidys

Sarepta stock falls after Elevidys fails to get backing by EU regulators

2h

Sarepta Therapeutics Acknowledges CHMP Negative Opinion for ELEVIDYS in the European Union

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, acknowledges that the ...

1don MSN

Sarepta Therapeutics (SRPT): “They Should Be Prosecuted,” Says Jim Cramer

We recently published 12 Stocks Jim Cramer Discussed As Analyzed Morgan Stanley’s Comments. Sarepta Therapeutics, Inc.

2don MSN

Arrowhead expects Sarepta to honor financial obligations

Arrowhead Pharmaceuticals (NASDAQ:ARWR) announced Wednesday that it expects its partner Sarepta Therapeutics (NASDAQ:SRPT), ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results